APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Non-Opioid Patch

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Non-Opioid Patch Market Outlook and Growth Opportunities 2026

Report ID 174017690421 December 2025190 pages

Choose your research edition.

Industry ResearchNon-Opioid Patch Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-Opioid Patch Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Non-Opioid Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-Opioid Patch Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-Opioid Patch Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Non-Opioid Patch market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Non-Opioid Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-Opioid Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-Opioid Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Non-Opioid Patch market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Non-Opioid Patch market include Teva Pharmaceutical Industries Ltd, Johnson and Johnson, Viatris Inc., Sorrento Therapeutics Inc., Purdue Pharma L.P., NEXGEL Advanced Hydrogel Solutions, Hisamitsu Pharmaceutical Co.,Inc., Grunenthal and Endo International plc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non-Opioid Patch market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-Opioid Patch and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-Opioid Patch sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-Opioid Patch market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-Opioid Patch Segment by Company

Teva Pharmaceutical Industries Ltd

Johnson and Johnson

Viatris Inc.

Sorrento Therapeutics Inc.

Purdue Pharma L.P.

NEXGEL Advanced Hydrogel Solutions

Hisamitsu Pharmaceutical Co.,Inc.

Grunenthal

Endo International plc.

Amneal Pharmaceuticals LLC

Non-Opioid Patch Segment by Type

Prescription Medicines

OTC Medicines

Non-Opioid Patch Segment by Application

Hospital Pharmacies

Drug Stores

Online Pharmacies

Non-Opioid Patch Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Non-Opioid Patch status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Non-Opioid Patch market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Non-Opioid Patch significant trends, drivers, influence factors in global and regions.

6. To analyze Non-Opioid Patch competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Opioid Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Opioid Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Opioid Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-Opioid Patch market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-Opioid Patch industry.

Chapter 3: Detailed analysis of Non-Opioid Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Non-Opioid Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Non-Opioid Patch in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Non-Opioid Patch Industry Trends Table 2. Non-Opioid Patch Industry Drivers Table 3. Non-Opioid Patch Industry Opportunities and Challenges Table 4. Non-Opioid Patch Industry Restraints Table 5. Global Non-Opioid Patch Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Non-Opioid Patch Revenue Share by Company (2021-2026) Table 7. Global Non-Opioid Patch Sales Volume by Company (k units) & (2021-2026) Table 8. Global Non-Opioid Patch Sales Volume Share by Company (2021-2026) Table 9. Global Non-Opioid Patch Average Price (US$/unit) of Company (2021-2026) Table 10. Global Non-Opioid Patch Company Ranking, (2024-2026) & (USD Million) Table 11. Global Non-Opioid Patch Key Company Manufacturing Base & Headquarters Table 12. Global Non-Opioid Patch Company, Product Type & Application Table 13. Global Non-Opioid Patch Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Non-Opioid Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Prescription Medicines Table 18. Significant Companies of OTC Medicines Table 19. Global Non-Opioid Patch Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Non-Opioid Patch Sales Volume by Type (2021-2026) & (k units) Table 21. Global Non-Opioid Patch Sales Volume by Type (2027-2032) & (k units) Table 22. Global Non-Opioid Patch Sales Volume Share by Type (2021-2026) Table 23. Global Non-Opioid Patch Sales Volume Share by Type (2027-2032) Table 24. Global Non-Opioid Patch Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Non-Opioid Patch Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Non-Opioid Patch Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Non-Opioid Patch Sales Value Share by Type (2021-2026) Table 28. Global Non-Opioid Patch Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Pharmacies Table 30. Significant Companies of Drug Stores Table 31. Significant Companies of Online Pharmacies Table 32. Global Non-Opioid Patch Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Non-Opioid Patch Sales Volume by Application (2021-2026) & (k units) Table 34. Global Non-Opioid Patch Sales Volume by Application (2027-2032) & (k units) Table 35. Global Non-Opioid Patch Sales Volume Share by Application (2021-2026) Table 36. Global Non-Opioid Patch Sales Volume Share by Application (2027-2032) Table 37. Global Non-Opioid Patch Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Non-Opioid Patch Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Non-Opioid Patch Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Non-Opioid Patch Sales Value Share by Application (2021-2026) Table 41. Global Non-Opioid Patch Sales Value Share by Application (2027-2032) Table 42. Global Non-Opioid Patch Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Non-Opioid Patch Sales by Region (2021-2026) & (k units) Table 44. Global Non-Opioid Patch Sales Market Share by Region (2021-2026) Table 45. Global Non-Opioid Patch Sales by Region (2027-2032) & (k units) Table 46. Global Non-Opioid Patch Sales Market Share by Region (2027-2032) Table 47. Global Non-Opioid Patch Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Non-Opioid Patch Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Non-Opioid Patch Sales Value Share by Region (2021-2026) Table 50. Global Non-Opioid Patch Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Non-Opioid Patch Sales Value Share by Region (2027-2032) Table 52. Global Non-Opioid Patch Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Non-Opioid Patch Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Non-Opioid Patch Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Non-Opioid Patch Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Non-Opioid Patch Sales by Country (2021-2026) & (k units) Table 57. Global Non-Opioid Patch Sales Market Share by Country (2021-2026) Table 58. Global Non-Opioid Patch Sales by Country (2027-2032) & (k units) Table 59. Global Non-Opioid Patch Sales Market Share by Country (2027-2032) Table 60. Global Non-Opioid Patch Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Non-Opioid Patch Sales Value Market Share by Country (2021-2026) Table 62. Global Non-Opioid Patch Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Non-Opioid Patch Sales Value Market Share by Country (2027-2032) Table 64. Teva Pharmaceutical Industries Ltd Company Information Table 65. Teva Pharmaceutical Industries Ltd Business Overview Table 66. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product Portfolio Table 68. Teva Pharmaceutical Industries Ltd Recent Development Table 69. Johnson and Johnson Company Information Table 70. Johnson and Johnson Business Overview Table 71. Johnson and Johnson Non-Opioid Patch Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Johnson and Johnson Non-Opioid Patch Product Portfolio Table 73. Johnson and Johnson Recent Development Table 74. Viatris Inc. Company Information Table 75. Viatris Inc. Business Overview Table 76. Viatris Inc. Non-Opioid Patch Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Viatris Inc. Non-Opioid Patch Product Portfolio Table 78. Viatris Inc. Recent Development Table 79. Sorrento Therapeutics Inc. Company Information Table 80. Sorrento Therapeutics Inc. Business Overview Table 81. Sorrento Therapeutics Inc. Non-Opioid Patch Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Sorrento Therapeutics Inc. Non-Opioid Patch Product Portfolio Table 83. Sorrento Therapeutics Inc. Recent Development Table 84. Purdue Pharma L.P. Company Information Table 85. Purdue Pharma L.P. Business Overview Table 86. Purdue Pharma L.P. Non-Opioid Patch Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Purdue Pharma L.P. Non-Opioid Patch Product Portfolio Table 88. Purdue Pharma L.P. Recent Development Table 89. NEXGEL Advanced Hydrogel Solutions Company Information Table 90. NEXGEL Advanced Hydrogel Solutions Business Overview Table 91. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product Portfolio Table 93. NEXGEL Advanced Hydrogel Solutions Recent Development Table 94. Hisamitsu Pharmaceutical Co.,Inc. Company Information Table 95. Hisamitsu Pharmaceutical Co.,Inc. Business Overview Table 96. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product Portfolio Table 98. Hisamitsu Pharmaceutical Co.,Inc. Recent Development Table 99. Grunenthal Company Information Table 100. Grunenthal Business Overview Table 101. Grunenthal Non-Opioid Patch Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Grunenthal Non-Opioid Patch Product Portfolio Table 103. Grunenthal Recent Development Table 104. Endo International plc. Company Information Table 105. Endo International plc. Business Overview Table 106. Endo International plc. Non-Opioid Patch Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Endo International plc. Non-Opioid Patch Product Portfolio Table 108. Endo International plc. Recent Development Table 109. Amneal Pharmaceuticals LLC Company Information Table 110. Amneal Pharmaceuticals LLC Business Overview Table 111. Amneal Pharmaceuticals LLC Non-Opioid Patch Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Amneal Pharmaceuticals LLC Non-Opioid Patch Product Portfolio Table 113. Amneal Pharmaceuticals LLC Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Non-Opioid Patch Distributors List Table 117. Non-Opioid Patch Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Non-Opioid Patch Product Image Figure 2. Global Non-Opioid Patch Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-Opioid Patch Sales Value (2021-2032) & (US$ Million) Figure 4. Global Non-Opioid Patch Sales (2021-2032) & (k units) Figure 5. Global Non-Opioid Patch Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Non-Opioid Patch Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Prescription Medicines Image Figure 10. OTC Medicines Image Figure 11. Global Non-Opioid Patch Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Non-Opioid Patch Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Non-Opioid Patch Sales Volume Share by Type (2021-2032) Figure 14. Global Non-Opioid Patch Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Non-Opioid Patch Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Non-Opioid Patch Sales Value Share by Type (2021-2032) Figure 17. Hospital Pharmacies Image Figure 18. Drug Stores Image Figure 19. Online Pharmacies Image Figure 20. Global Non-Opioid Patch Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Non-Opioid Patch Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Non-Opioid Patch Sales Volume Share by Application (2021-2032) Figure 23. Global Non-Opioid Patch Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Non-Opioid Patch Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Non-Opioid Patch Sales Value Share by Application (2021-2032) Figure 26. Global Non-Opioid Patch Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Non-Opioid Patch Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Non-Opioid Patch Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Non-Opioid Patch Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Non-Opioid Patch Sales Value (2021-2032) & (US$ Million) Figure 31. North America Non-Opioid Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Non-Opioid Patch Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Non-Opioid Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Non-Opioid Patch Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Non-Opioid Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Non-Opioid Patch Sales Value (2021-2032) & (US$ Million) Figure 37. South America Non-Opioid Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Non-Opioid Patch Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Non-Opioid Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Non-Opioid Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Non-Opioid Patch Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Non-Opioid Patch Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription Medicines
  • OTC Medicines
Applications
  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
Companies covered
  • Teva Pharmaceutical Industries Ltd
  • Johnson and Johnson
  • Viatris Inc.
  • Sorrento Therapeutics Inc.
  • Purdue Pharma L.P.
  • NEXGEL Advanced Hydrogel Solutions
  • Hisamitsu Pharmaceutical Co.,Inc.
  • Grunenthal
  • Endo International plc.
  • Amneal Pharmaceuticals LLC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non-Opioid Patch Sales Value (2021-2032)
  4. 1.2.2 Global Non-Opioid Patch Sales Volume (2021-2032)
  5. 1.2.3 Global Non-Opioid Patch Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Non-Opioid Patch Market Dynamics
  1. 2.1 Non-Opioid Patch Industry Trends
  2. 2.2 Non-Opioid Patch Industry Drivers
  3. 2.3 Non-Opioid Patch Industry Opportunities and Challenges
  4. 2.4 Non-Opioid Patch Industry Restraints
3 Non-Opioid Patch Market by Company
  1. 3.1 Global Non-Opioid Patch Company Revenue Ranking in 2025
  2. 3.2 Global Non-Opioid Patch Revenue by Company (2021-2026)
  3. 3.3 Global Non-Opioid Patch Sales Volume by Company (2021-2026)
  4. 3.4 Global Non-Opioid Patch Average Price by Company (2021-2026)
  5. 3.5 Global Non-Opioid Patch Company Ranking (2024-2026)
  6. 3.6 Global Non-Opioid Patch Company Manufacturing Base and Headquarters
  7. 3.7 Global Non-Opioid Patch Company Product Type and Application
  8. 3.8 Global Non-Opioid Patch Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Non-Opioid Patch Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Non-Opioid Patch Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Non-Opioid Patch Market by Type
  1. 4.1 Non-Opioid Patch Type Introduction
  2. 4.1.1 Prescription Medicines
  3. 4.1.2 OTC Medicines
  4. 4.2 Global Non-Opioid Patch Sales Volume by Type
  5. 4.2.1 Global Non-Opioid Patch Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Non-Opioid Patch Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Non-Opioid Patch Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Non-Opioid Patch Sales Value by Type
  9. 4.3.1 Global Non-Opioid Patch Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Non-Opioid Patch Sales Value by Type (2021-2032)
  11. 4.3.3 Global Non-Opioid Patch Sales Value Share by Type (2021-2032)
5 Non-Opioid Patch Market by Application
  1. 5.1 Non-Opioid Patch Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Drug Stores
  4. 5.1.3 Online Pharmacies
  5. 5.2 Global Non-Opioid Patch Sales Volume by Application
  6. 5.2.1 Global Non-Opioid Patch Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non-Opioid Patch Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Non-Opioid Patch Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Non-Opioid Patch Sales Value by Application
  10. 5.3.1 Global Non-Opioid Patch Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Non-Opioid Patch Sales Value by Application (2021-2032)
  12. 5.3.3 Global Non-Opioid Patch Sales Value Share by Application (2021-2032)
6 Non-Opioid Patch Regional Sales and Value Analysis
  1. 6.1 Global Non-Opioid Patch Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-Opioid Patch Sales by Region (2021-2032)
  3. 6.2.1 Global Non-Opioid Patch Sales by Region: 2021-2026
  4. 6.2.2 Global Non-Opioid Patch Sales by Region (2027-2032)
  5. 6.3 Global Non-Opioid Patch Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Non-Opioid Patch Sales Value by Region (2021-2032)
  7. 6.4.1 Global Non-Opioid Patch Sales Value by Region: 2021-2026
  8. 6.4.2 Global Non-Opioid Patch Sales Value by Region (2027-2032)
  9. 6.5 Global Non-Opioid Patch Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Non-Opioid Patch Sales Value (2021-2032)
  12. 6.6.2 North America Non-Opioid Patch Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Non-Opioid Patch Sales Value (2021-2032)
  15. 6.7.2 Europe Non-Opioid Patch Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Non-Opioid Patch Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Non-Opioid Patch Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Non-Opioid Patch Sales Value (2021-2032)
  21. 6.9.2 South America Non-Opioid Patch Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Non-Opioid Patch Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Non-Opioid Patch Sales Value Share by Country, 2025 VS 2032
7 Non-Opioid Patch Country-level Sales and Value Analysis
  1. 7.1 Global Non-Opioid Patch Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Non-Opioid Patch Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Non-Opioid Patch Sales by Country (2021-2032)
  4. 7.3.1 Global Non-Opioid Patch Sales by Country (2021-2026)
  5. 7.3.2 Global Non-Opioid Patch Sales by Country (2027-2032)
  6. 7.4 Global Non-Opioid Patch Sales Value by Country (2021-2032)
  7. 7.4.1 Global Non-Opioid Patch Sales Value by Country (2021-2026)
  8. 7.4.2 Global Non-Opioid Patch Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Non-Opioid Patch Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Non-Opioid Patch Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Non-Opioid Patch Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries Ltd
  2. 8.1.1 Teva Pharmaceutical Industries Ltd Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Ltd Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Ltd Recent Developments
  7. 8.2 Johnson and Johnson
  8. 8.2.1 Johnson and Johnson Company Information
  9. 8.2.2 Johnson and Johnson Business Overview
  10. 8.2.3 Johnson and Johnson Non-Opioid Patch Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Johnson and Johnson Non-Opioid Patch Product Portfolio
  12. 8.2.5 Johnson and Johnson Recent Developments
  13. 8.3 Viatris Inc.
  14. 8.3.1 Viatris Inc. Company Information
  15. 8.3.2 Viatris Inc. Business Overview
  16. 8.3.3 Viatris Inc. Non-Opioid Patch Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Viatris Inc. Non-Opioid Patch Product Portfolio
  18. 8.3.5 Viatris Inc. Recent Developments
  19. 8.4 Sorrento Therapeutics Inc.
  20. 8.4.1 Sorrento Therapeutics Inc. Company Information
  21. 8.4.2 Sorrento Therapeutics Inc. Business Overview
  22. 8.4.3 Sorrento Therapeutics Inc. Non-Opioid Patch Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sorrento Therapeutics Inc. Non-Opioid Patch Product Portfolio
  24. 8.4.5 Sorrento Therapeutics Inc. Recent Developments
  25. 8.5 Purdue Pharma L.P.
  26. 8.5.1 Purdue Pharma L.P. Company Information
  27. 8.5.2 Purdue Pharma L.P. Business Overview
  28. 8.5.3 Purdue Pharma L.P. Non-Opioid Patch Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Purdue Pharma L.P. Non-Opioid Patch Product Portfolio
  30. 8.5.5 Purdue Pharma L.P. Recent Developments
  31. 8.6 NEXGEL Advanced Hydrogel Solutions
  32. 8.6.1 NEXGEL Advanced Hydrogel Solutions Company Information
  33. 8.6.2 NEXGEL Advanced Hydrogel Solutions Business Overview
  34. 8.6.3 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product Portfolio
  36. 8.6.5 NEXGEL Advanced Hydrogel Solutions Recent Developments
  37. 8.7 Hisamitsu Pharmaceutical Co.,Inc.
  38. 8.7.1 Hisamitsu Pharmaceutical Co.,Inc. Company Information
  39. 8.7.2 Hisamitsu Pharmaceutical Co.,Inc. Business Overview
  40. 8.7.3 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product Portfolio
  42. 8.7.5 Hisamitsu Pharmaceutical Co.,Inc. Recent Developments
  43. 8.8 Grunenthal
  44. 8.8.1 Grunenthal Company Information
  45. 8.8.2 Grunenthal Business Overview
  46. 8.8.3 Grunenthal Non-Opioid Patch Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Grunenthal Non-Opioid Patch Product Portfolio
  48. 8.8.5 Grunenthal Recent Developments
  49. 8.9 Endo International plc.
  50. 8.9.1 Endo International plc. Company Information
  51. 8.9.2 Endo International plc. Business Overview
  52. 8.9.3 Endo International plc. Non-Opioid Patch Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Endo International plc. Non-Opioid Patch Product Portfolio
  54. 8.9.5 Endo International plc. Recent Developments
  55. 8.10 Amneal Pharmaceuticals LLC
  56. 8.10.1 Amneal Pharmaceuticals LLC Company Information
  57. 8.10.2 Amneal Pharmaceuticals LLC Business Overview
  58. 8.10.3 Amneal Pharmaceuticals LLC Non-Opioid Patch Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Amneal Pharmaceuticals LLC Non-Opioid Patch Product Portfolio
  60. 8.10.5 Amneal Pharmaceuticals LLC Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non-Opioid Patch Value Chain Analysis
  2. 9.1.1 Non-Opioid Patch Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non-Opioid Patch Sales Mode & Process
  6. 9.2 Non-Opioid Patch Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non-Opioid Patch Distributors
  9. 9.2.3 Non-Opioid Patch Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst